What new Dupilumab data suggest about long-term immune control in allergic disease at Regeneron Pharmaceuticals
Ryerson Holding (NYSE: RYI) finalises Olympic Steel acquisition as North American metals consolidation accelerates
Read More 6 minute read Pharma Industry News CD388 in focus as Merck announces $9.2bn deal for Cidara Therapeutics (NASDAQ: CDTX) Merck is acquiring Cidara Therapeutics for $9.2B to expand into long-acting antivirals. Find out what makes CD388 a potential flu game-changer. byVenkateshNovember 19, 2025